Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Preferred Stock Liabilities: 2020

Historic Preferred Stock Liabilities for Terns Pharmaceuticals (TERN) over the last 1 years, with Dec 2020 value amounting to $186.0 million.

  • Terns Pharmaceuticals' Preferred Stock Liabilities was N/A to $186.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $186.0 million, marking a year-over-year change of. This contributed to the annual value of $186.0 million for FY2020, which is N/A change from last year.
  • Terns Pharmaceuticals' Preferred Stock Liabilities amounted to $186.0 million in FY2020.
  • In the past 5 years, Terns Pharmaceuticals' Preferred Stock Liabilities registered a high of $186.0 million during FY2020, and its lowest value of $186.0 million during FY2020.
  • Its 1-year average for Preferred Stock Liabilities is $186.0 million, with a median of $186.0 million in 2020.